Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Ajanta Pharma Ltd.
BSE Code 532331
ISIN Demat INE031B01049
Book Value 282.56
NSE Code AJANTPHARM
Dividend Yield % 1.79
Market Cap 356211.83
P/E 41.72
EPS 68.36
Face Value 2  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
20-Dec-2024 5570 2122 38.10
19-Dec-2024 3011 810 26.90
18-Dec-2024 1379 411 29.80
17-Dec-2024 3501 1645 46.99
16-Dec-2024 4033 1468 36.40
13-Dec-2024 3350 1157 34.54
12-Dec-2024 5287 1930 36.50
11-Dec-2024 2904 1273 43.84
10-Dec-2024 3205 1166 36.38
09-Dec-2024 4602 1724 37.46
06-Dec-2024 3825 1777 46.46
05-Dec-2024 1622 997 61.47
04-Dec-2024 2360 1413 59.87
03-Dec-2024 4400 2423 55.07
02-Dec-2024 2339 318 13.60
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.